Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Cognitive Rehabilitation on the Cognitive Performance in Multiple Sclerosis: A Randomized Controlled Trial Publisher



Shahpouri M1 ; Barekatain M2 ; Tavakoli M3 ; Sanaei S1 ; Shaygannejad V1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Psychology, School of Educational Sciences and Psychology, University of Isfahan, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2019


Abstract

Multiple sclerosis (MS) can involve cognitive entities, including memory, attention, performance, and information processing. Furthermore, MS causes depression and negatively affects the quality of life (QOL). This study was aimed to assess the efficacy of cognitive rehabilitation on cognitive entities of MS patients. Materials and Methods: This is a clinical trial study conducted on 56 MS patients in 2016-2017. Patients were randomly divided into two Groups of A (cognitive rehabilitation) and B (control group). Patients were evaluated in terms of memory, attention, QOL, and depression. Questionnaires included Abbreviated Mental Test, Prospective and Retrospective Memory Questionnaire, Everyday Memory Questionnaire, Digit Spam test for attention assessment, QOL-54 questionnaire, and Second version of Beck questionnaire assessing depression. They were filled through an interview before the study initiation, and then, the intervention group underwent ten sessions of cognitive rehabilitation and questionnaires refilled within 3 months after study initiation. Outcomes of the two groups were compared. Results: Memory, attention, QOL, and depression improved significantly following the intervention in cases (P < 0.05), while no significant change was observed among controls (P > 0.05). Comparison of cases and controls in the second evaluation showed a significant difference between cases and controls (P < 0.05). Conclusion: Ten sessions of cognitive rehabilitation could significantly improve MS patients' cognitive performance. Moreover, this approach affected their QOL and sense of depression in a decisive trend. It can be concluded that cognitive rehabilitation can successfully affect numerous aspects of MS patients, while numerous medical therapies may be required for treatment of each mere aspect. Further evaluations are strongly recommended. © 2019 Journal of Research in Medical Sciences | Published by Wolters Kluwer - Medknow.
Related Docs
View other Related Docs
1. Comparison of Cognitive Rehabilitation Versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression Among Multiple Sclerosis Patients, Neurology Research International (2020)
2. Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial, International Journal of Preventive Medicine (2020)
3. Memory Rehabilitation for the Working Memory of Patients With Multiple Sclerosis (Ms), Journal of Clinical and Experimental Neuropsychology (2018)
4. Evaluating the Effectiveness of Cognitive Rehabilitation on Everyday Memory in Multiple Sclerosis Patients, Neuropsychological Rehabilitation (2020)
5. Fatigue, Depression, and Health-Related Quality of Life in Patients With Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2012)
6. Computerized Cognitive Rehabilitation in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Caspian Journal of Internal Medicine (2025)
7. Depression and Cognitive Performances in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2015)
8. The Effect of Group Cognitive Behavioral Therapy on Stress, Anxiety, and Depression of Women With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2017)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (70)
Fereshteh Ashtari (29)
Other Related Docs
9. Impact of the Covid-19 Pandemic on the Psychological Status and Cortisol Level of Multiple Sclerosis Patients, Neuropsychological Rehabilitation (2023)
10. Coping With Health Injuries and Problems: Psychometric Evaluation of an Iranian Scale for Behavioral Rehabilitation Strategies in Patients With Multiple Sclerosis, International Journal of Body, Mind and Culture (2023)
11. Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis, Canadian Journal of Neurological Sciences (2008)
12. Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (Ms)-A Longitudinal and Pilot Study, Frontiers in Psychiatry (2018)
13. The Frequency of Cognitive Dysfunction Among Multiple Sclerosis Patients With Mild Physical Disability, Journal of Isfahan Medical School (2012)
14. Clinical and Demographical Characteristics of Primary Progressive Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2007)
15. Physical Activity Interventions Can Improve Emotion Regulation and Dimensions of Empathy in Persons With Multiple Sclerosis: An Exploratory Study, Multiple Sclerosis and Related Disorders (2020)
16. Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Placebo-Controlled, Double-Blind Pilot Study, International Journal of Neuroscience (2013)
17. The Persian Version of Community Integration Questionnaire in Persons With Multiple Sclerosis: Translation, Reliability, Validity, and Factor Analysis, Disability and Rehabilitation (2013)
18. Cognitive Rehabilitation in Patients With Nonamnestic Mild Cognitive Impairment, Journal of Research in Medical Sciences (2016)
19. Psychometric Assessment of the Persian Version of the Patient Determined Disease Steps Scale in Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder, Current Journal of Neurology (2022)
20. Effect of Aquatic Exercise Training on Fatigue and Health-Related Quality of Life in Patients With Multiple Sclerosis, Archives of Physical Medicine and Rehabilitation (2012)
21. Potential of Modified Mediterranean Diet to Improve Quality of Life and Fatigue Severity in Multiple Sclerosis Patients: A Single-Center Randomized Controlled Trial, International Journal of Food Properties (2020)
22. Compared to an Active Control Condition, in Persons With Multiple Sclerosis Two Different Types of Exercise Training Improved Sleep and Depression, But Not Fatigue, Paresthesia, and Intolerance of Uncertainty, Multiple Sclerosis and Related Disorders (2019)
23. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
24. Working Memory Dysfunction Differs Between Secondary Progressive and Relapsing Multiple Sclerosis: Effects of Clinical Phenotype, Age, Disease Duration, and Disability, Multiple Sclerosis and Related Disorders (2023)
25. In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise, Frontiers in Psychiatry (2019)
26. The Relationship Between Cognitive Disorders and Hippocampal Angle in Patients Multiple Sclerosis, Journal of Isfahan Medical School (2019)
27. Iranian Specialists’ Approach to Treatment Escalation in Multiple Sclerosis Patients With Cognitive Impairment, Current Journal of Neurology (2023)
28. The Contribution of Self-Disclosure to the Prediction of Mood Symptoms in Patients With Multiple Sclerosis, Current Journal of Neurology (2021)
29. The Effects of Motivational Interviewing on Health Promoting Behaviors of Patients With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2016)
30. Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity), Multiple Sclerosis and Related Disorders (2024)
31. Effectiveness of Cognitive Behavioral Therapy on the Quality of Sleep in Women With Multiple Sclerosis: A Randomized Controlled Trial Study, International Journal of Community Based Nursing and Midwifery (2016)
32. Effectiveness of Schema Therapy on Anxiety, Depression, Fatigue, Quality of Life, and Sleep in Patients With Multiple Sclerosis: A Randomized Controlled Trial, Middle East Journal of Rehabilitation and Health Studies (2024)
33. Psychological Well-Being in People With Multiple Sclerosis in an Iranian Population, Journal of Research in Medical Sciences (2015)
34. The Effectiveness of Mindfulness-Integrated Cognitive Behavior Therapy on Depression, Anxiety, and Stress in Females With Multiple Sclerosis: A Single Blind Randomized Controlled Trial, Iranian Red Crescent Medical Journal (2017)
35. Effects of Acceptance and Commitment Therapy (Act) and Mindfulness-Based Stress Reduction (Mbsr) on Symptoms and Emotional Competencies in Individuals With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
36. Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis, Scientific Reports (2023)
37. Comparative Study of Quality of Life, Anxiety, Depression, and Fatigue Among Patients With Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: The First Report From Iran, Multiple Sclerosis and Related Disorders (2018)
38. Prevalence of Cognitive Impairment (Ci) in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Caspian Journal of Internal Medicine (2024)
39. The Effect of Mindfulness-Based Stress Reduction (Mbsr) Therapy on Quality of Life in Women With Multiple Sclerosis, Ahvaz, Iran, Journal of Caring Sciences (2019)
40. Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials, Heliyon (2024)
41. Category-Semantic Memory Deficit in Multiple Sclerosis, Tehran University Medical Journal (2009)
42. Sexual Dysfunction in Women With Multiple Sclerosis: Prevalence and Impact on Quality of Life, BMC Urology (2020)
43. Risk Factors of Severe Covid-19 in People With Multiple Sclerosis : A Systematic Review and Meta-Analysis, Revue Neurologique (2022)
44. Risk of Depression After Parkinson's Disease, Stroke, Multiple Sclerosis, and Migraine in an Iranian Population and Assess Psychometric Characteristics of Three Prevalent Depression Questionnaires, IBRO Neuroscience Reports (2024)
45. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
46. The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial, Food and Function (2023)
47. Sexual Function and Related Predictors in Male With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Journal of Sexual Medicine (2025)
48. Effectiveness of Multiple Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis: Causal Inference to Emulate a Multiarm Randomised Trial, Journal of Neurology, Neurosurgery and Psychiatry (2023)
49. Cognitive Function and Brain Magnetic Resonance Imaging Profiles in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis, Journal of Research in Medical Sciences (2024)
50. Association Between Diffusion Tensor Imaging Measurements and Cognitive Performances in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2025)